+92-3027708327

10% off your first order — use code MEDICINE10 at checkout

MedicinePrices.pk
Rx Health Track Login
Cart 0

NO PRODUCTS IN THE CART

Hilton Pharma

Xenglu Lin 10/5mg Tablets 14s

In stock Per Box
Rs 450 Rs 428 Save Rs 22 (5% off)

Product highlights

  • Buy authentic pharmaceutical products from Online Pharmacy & Medical Store Online or Find a Fitwell Pharmacy near you.
Select quantity
Or enter quantity

Bulk order quotation

Hospitals, clinics & retailers — request special pricing for large quantities.

Quote via WhatsApp

Customer reviews

  • Hassan H. 12-Mar-2025 || 10:17 PM

    Received xenglu lin 10/5mg tablets 14s in good condition. Tracking updates were accurate. Five stars.

  • Shahid R. 15-Jul-2025 || 09:17 AM

    Product xenglu lin 10/5mg tablets 14s works fine for daily use. Delivery to Multan took 3 business days.

  • Tariq Z. 26-Aug-2025 || 04:45 AM

    Recommended by my doctor; found xenglu lin 10/5mg tablets 14s here at a fair price. Checkout was simple.

  • Sadia N. 01-Jan-2025 || 10:57 PM

    Genuine xenglu lin 10/5mg tablets 14s — sealed pack and correct expiry. Delivered within 2 days in Peshawar.

  • Maryam H. 15-Oct-2025 || 03:50 AM

    Good for repeat purchases. xenglu lin 10/5mg tablets 14s stock was available when other sites were out.

  • Kashif K. 29-Apr-2026 || 10:37 PM

    Good experience overall. xenglu lin 10/5mg tablets 14s price beat the market near Multan.

  • Shahid Q. 07-Apr-2025 || 10:59 PM

    Asked questions about xenglu lin 10/5mg tablets 14s on WhatsApp — got a clear reply within minutes.

  • Ali P. 23-Sep-2025 || 08:49 AM

    Fast delivery of xenglu lin 10/5mg tablets 14s to Hyderabad. Packaging was secure and invoice was included.

  • Bilal Q. 18-Mar-2025 || 01:22 AM

    No complaints about xenglu lin 10/5mg tablets 14s. Would suggest adding more payment options, otherwise great.

  • Sana T. 21-Feb-2026 || 12:13 AM

    Excellent communication about xenglu lin 10/5mg tablets 14s availability. No fake “in stock” trap.

  • Danish K. 07-Jun-2026 || 07:59 AM

    Reasonable delivery fee for xenglu lin 10/5mg tablets 14s to Rawalpindi. Product exactly as shown online.

  • Kashif H. 11-Jun-2025 || 07:22 AM

    Five-star for xenglu lin 10/5mg tablets 14s quality; four-star only because I wanted Sunday delivery.

  • Asad R. 23-Dec-2025 || 03:54 AM

    Will continue xenglu lin 10/5mg tablets 14s from this store — consistent batches and polite support.

  • Rabia K. 04-Mar-2026 || 03:47 AM

    Reliable source for xenglu lin 10/5mg tablets 14s in Pakistan. Invoice helped for office reimbursement.

  • Usman M. 20-Aug-2025 || 07:41 AM

    Happy that xenglu lin 10/5mg tablets 14s is sourced properly. Feels like a real licensed pharmacy operation.

  • Shahid Q. 10-Apr-2026 || 09:16 AM

    Received correct quantity of xenglu lin 10/5mg tablets 14s. Strip seal was intact. Happy with the purchase.

  • Amna J. 09-Nov-2025 || 08:24 AM

    Minor delay for xenglu lin 10/5mg tablets 14s due to rain in Faisalabad, but team kept me updated.

  • Danish R. 03-Mar-2025 || 08:15 AM

    Smooth ordering process for xenglu lin 10/5mg tablets 14s. Email confirmation and dispatch SMS were helpful.

  • Bilal K. 10-Jan-2026 || 09:22 AM

    Using xenglu lin 10/5mg tablets 14s as prescribed — no issues with quality. Will order again from MedicinePrices.pk.

  • Ahmed Z. 18-May-2025 || 02:53 AM

    Quick response when I asked about substitutes for xenglu lin 10/5mg tablets 14s. Good pharmacy ethics.

  • Hamza K. 30-Jul-2025 || 11:06 PM

    Trust factor is high for xenglu lin 10/5mg tablets 14s here. Proper GST-style receipt provided.

Write a review

Description

Xenglu-Lin Tablets Specification

Requires Prescription (YES/NO)

Yes

Generics

Empagliflozin + Linagliptin

Used For

Diabetes

How it works

Empagliflozin Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, Empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion. Linagliptin Linagliptin is an inhibitor of DPP-4, an enzyme that degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Thus, Linagliptin increases the concentrations of active incretin hormones, stimulating the release of insulin in a glucose-dependent manner and decreasing the levels of glucagon in the circulation. Both incretin hormones are involved in the physiological regulation of glucose homeostasis. GLP-1 and GIP increase insulin biosynthesis and secretion from pancreatic beta cells in the presence of normal and elevated blood glucose levels. Furthermore, GLP-1 also reduces glucagon secretion from pancreatic alpha cells, resulting in a reduction in hepatic glucose output.

Xenglu-Lin Tablets Usage And Safety

Dosage

Empagliflozin + Linagliptin

Side Effects

Common: Urinary tract infection (including pyelonephritis and urosepsis), vaginal moniliasis, vulvovaginitis, balanitis and other genital infections, nasopharyngitis, hypoglycaemia (when used with sulphonylurea or insulin), thirst, cough, pruritus, rash, increased urination, amylase increased and lipase increased. Uncommon: Hypersensitivity, angioedema, urticarial, pancreatitis, volume depletion, dysuria, hematocrit increased, serum lipids increased and blood creatinine increased/glomerular filtration rate decreased. Not known: Necrotising fasciitis of the perineum (Fournier´s gangrene) and bullous pemphigoid.

Drug Interactions

Diuretics : Coadministration of Empagliflozin with diuretics resulted in increased urine volume and frequency of voids, which might enhance the potential for volume depletion. Before initiating Empagliflozin + Linagliptin , assess volume status and renal function. In patients with volume depletion, correct this condition before initiating therapy. Monitor for signs and symptoms of volume depletion and renal function after initiating therapy. Interference with 1,5-anhydroglucitol (1,5-AG) Assay Measurements of 1,5-AG are unreliable in assessing glycemic control in patients taking SGLT2 inhibitors. Monitoring glycemic control with 1,5-AG assay is not recommended. Use alternative methods to monitor glycemic control. Inducers of P-glycoprotein or CYP3A4 Enzymes Rifampin decreased Linagliptin exposure, suggesting that the efficacy of Linagliptin may be reduced when administered in combination with a strong P-gp or CYP3A4 inducer. Use of alternative treatments is strongly recommended when Linagliptin is to be administered with a strong P-gp or CYP3A4 inducer.

Indication

Empagliflozin + Linagliptin are indicated as an adjunct to diet and exercise in adults aged 18 years and older with type 2 diabetes mellitu s: to improve glycemic control when metformin and/or sulphonylurea (SU) and monotherapy of either of Empagliflozin and Linagliptin do not provide adequate glycemic control. - when already being treated with the free combination of Empagliflozin and Linagliptin. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.

When not to Use

The combination of Empagliflozin + Linagliptin is contraindicated in patients with hypersensitivity to the active substances, to any other Sodium-Glucose-Co-Transporter-2 (SGLT2) inhibitor, to any other Dipeptidyl-Peptidase-4 (DPP-4) inhibitor, or to any of the excipients of the product.

Xenglu-Lin Tablets Precautions

Precaution

Use of dipeptidyl peptidase-4 (DPP-4) inhibitors has been associated with a risk of developing acute pancreatitis. Acute pancreatitis has been observed in patients taking Linagliptin. If pancreatitis is suspected, Empagliflozin + Linagliptin Tablets should be discontinued; if acute pancreatitis is confirmed, Empagliflozin + Linagliptin should not be restarted. Caution should be exercised in patients with a history of pancreatitis.

Xenglu-Lin Tablets Warnings

Warning 1

Caution should be exercised in patients for whom an Empagliflozin-induced drop in blood pressure could pose a risk, such as patients with known cardiovascular disease, patients on anti-hypertensive therapy (e.g. thiazide and loop diuretics with a history of hypotension or patients aged 75 years and older).

Warning 2

An increase in cases of lower limb amputation (primarily of the toe) has been observed. Like for all diabetic patients it is important to counsel patients on routine preventative foot-care.

Warning 3

Treatment with SGLT2 inhibitors increases the risk for urinary tract infections. Evaluate patients for signs and symptoms of urinary tract infections and treat promptly, if indicated .

Xenglu-Lin Tablets Additional Information

Pregnancy category

Always consult your physician before using any medicine.

Storage (YES/NO)

Store this medicine at room temperature, away from direct light and heat.

Product information
Unit
Per Box
SKU
#2070
>